Worth reading
32Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 7 April 2026Incoming appointee
1 itemScheduled Appointment Date24 June 2026. Formal approval is scheduled at the Annual General Meeting of Shareholders to be held on the same date and at the subsequent Board of Directors meeting.
Hyakutake Naoki (百武 尚樹)
Previous positionDirector, Senior Managing Executive Officer, in charge of overall Human Resources, corporate ethics and the nursing care business
New positionRepresentative Director, Senior Managing Executive Officer, in charge of overall Human Resources, corporate ethics and the nursing care business
生年月日 15 May 1964入社年 2019所有株式数 18,800 shares (as of 31 March 2026)
Departing officer
1 itemDate of departure24 June 2026
Kayaki Ikuji (栢木 伊久二)Next role stated
Former PositionRepresentative Director, Group COO and President and Executive Officer, in charge of quality management
New positionSpecial Adviser
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Reason for departure
Retirement from the positions of Representative Director, Group COO and President and Executive Officer
Whether the incumbent will remain in office (whether they will retain their position)
Will not remain on the Board of Directors
Shareholders’ meeting approvalRequired. Formal approval is scheduled at the Annual General Meeting of Shareholders to be held on 24 June 2026 and at the subsequent Board of Directors meeting.
Reason for change
Following the retirement of the Representative Director, Group COO and President and Executive Officer, 1 new Representative Director will be appointed.
| Item | Details |
|---|---|
| Resolution date | 7 April 2026 |
| Scheduled Appointment Date | 24 June 2026. Formal approval is scheduled at the Annual General Meeting of Shareholders to be held on the same date and at the subsequent Board of Directors meeting. |
| Date of departure | 24 June 2026 |
| Name of appointee | Hyakutake Naoki (百武 尚樹) |
| Appointee's new position | Representative Director, Senior Managing Executive Officer, in charge of overall Human Resources, corporate ethics and the nursing care business |
| Appointee's previous position | Director, Senior Managing Executive Officer, in charge of overall Human Resources, corporate ethics and the nursing care business |
| Appointee's date of birth | 15 May 1964 |
| Year the appointee joined the Company | 2019 |
| Number of shares held by the appointee | 18,800 shares (as of 31 March 2026) |
| Name of departing officer | Kayaki Ikuji (栢木 伊久二) |
| Former position of departing officer | Representative Director, Group COO and President and Executive Officer, in charge of quality management |
| New position of departing officer | Special Adviser |
| Reason for departure | Retirement from the positions of Representative Director, Group COO and President and Executive Officer |
| Whether the incumbent will remain in office | Will not remain on the Board of Directors |
| Reason for change | Following the retirement of the Representative Director, Group COO and President and Executive Officer, 1 new Representative Director will be appointed. |
| Subject to Approval by the General Meeting of Shareholders | Required. Formal approval is scheduled at the Annual General Meeting of Shareholders to be held on 24 June 2026 and at the subsequent Board of Directors meeting. |
Items this document does not state (5)
Reasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To appoint 1 new Representative Director following the retirement of the Representative Director, Group COO and President and Executive Officer.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.